Applications For The Salix Gastrointestinal Health Scholars Program Will Be Accepted Beginning Nov. 1, 2019 BRIDGEWATER, N.J., Oct. 30, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical

PHILADELPHIA, Oct. 30, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2020 first quarter on Wednesday, November 6, 2019, after the market closes. Lannett management will host a conference call that same afternoon at 4:30 p.m. Eastern Time

IRVING, Texas and ORANGE, Calif., Oct. 30, 2019 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that St. Joseph Hospital has become the 30th member of its

HOUSTON and VANCOUVER, Oct. 30, 2019 /PRNewswire/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Corporation") announced that, pursuant to its stock option plan, it has granted incentive stock options to non – executive members of the Corporation's board of directors to purchase up to an aggregate of 225,000 common sh

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended September 30, 2019."We are pleased to see continued growth during the quarter in the total number of U.S. patients treated with our prostacyclin product franc

SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™ (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations (FLT3mut+) detected using Invivoscrib

TAMPA, Fla., Oct. 30, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") today reported results for the quarter ended September 30, 2019. As determined under generally accepted accounting principles (GAAP), net income for the third quarter of 2019 was $241.0 million, or

SAN FRANCISCO, Oct. 30, 2019 /PRNewswire/ -- Today Doximity, the largest professional medical network, released a new study that illuminates an emerging women's cancer care crisis. Cancer is

NORTH CHICAGO, Ill., Oct. 30, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of October 28, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,821,109 shares of common stock with a par value of $0.01

ROSEMONT, Ill., Oct. 30, 2019 /PRNewswire/ -- A large new study has found that an artery disease that mostly affects legs and feet is associated with increased use of opioids, the Society for Vascular Surgery reports. Researchers discovered that some patients who had a procedure to improve pain from poor circulation actually increased their use of opioids after treatment